Sherbrooke Park Advisers’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,264
Closed -$82.1K 787
2025
Q1
$82.1K Buy
15,264
+1,631
+12% +$11.1K 0.04% 529
2024
Q4
$102K Buy
13,633
+869
+7% +$7.14K 0.03% 668
2024
Q3
$115K Buy
+12,764
New +$132K 0.03% 824

Other funds holding ULBI

Sherbrooke Park Advisers's ULBI Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of Ultralife (ULBI) in Q2 2025, closing a stake of 15,264 shares — an estimated $82.1K sold.

Sherbrooke Park Advisers first reported a position in ULBI in Q3 2024 and held it in 3 quarters. The position peaked at $115K in Q3 2024. 63 funds tracked by Wall St. Rank hold ULBI as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining Ultralife position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 15,264 Ultralife shares in Q2 2025, an estimated $82.1K.
  • Sherbrooke Park Advisers first reported a position in Ultralife in Q3 2024 and held it in 3 quarters.
  • Sherbrooke Park Advisers's Ultralife position peaked at $115K in Q3 2024.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.